TAMs promote angiogenesis in MM through vascular mimicry and secretion of vascular endothelial growth factor (VEGF) as well as matrix metalloproteases, synergizing with the MM cells’ own angiogenic properties [52,53,54]. Here, VEGFA is linked to Miyoshi myopathy.